- Article
Outcome after Systemic Thrombolysis Is Predicted by Age and Stroke Severity: An Open Label Experience with Recombinant Tissue Plasminogen Activator and Tirofiban
- Rudiger J. Seitz,
- Judith Sukiennik and
- Mario Siebler
Stroke patients can recover upon intravenous thrombolysis but remain impaired in lacking recanalization. We sought to investigate the clinical effect of systemic thrombolysis with an intravenous bolus of 20 mg recombinant tissue plasminogen activator...

